Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rivka Schwartz"'
Autor:
Fadi Towfic, Jason M Funt, Kevin D Fowler, Shlomo Bakshi, Eran Blaugrund, Maxim N Artyomov, Michael R Hayden, David Ladkani, Rivka Schwartz, Benjamin Zeskind
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e83757 (2014)
For decades, policies regarding generic medicines have sought to provide patients with economical access to safe and effective drugs, while encouraging the development of new therapies. This balance is becoming more challenging for physicians and reg
Externí odkaz:
https://doaj.org/article/d9ac4720e37d456aa3e0668f876f8ecc
Autor:
Arthur Komlosh, Tal Hasson, Shlomo Bakshi, Michael R. Hayden, Kevin D. Fowler, Augusto Grinspan, Tal Birnberg, Maxim N. Artyomov, Liat Hayardeny, Fadi Towfic, Jason M. Funt, Benjamin Zeskind, Rivka Schwartz, Iris Grossman, David Ladkani, Daphna Laifenfeld, Sarah Kolitz
Publikováno v:
Scientific Reports
Glatiramer Acetate (GA) has provided safe and effective treatment for multiple sclerosis (MS) patients for two decades. It acts as an antigen, yet the precise mechanism of action remains to be fully elucidated and no validated pharmacokinetic or phar
Publikováno v:
Non-Biological Complex Drugs ISBN: 9783319162409
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a5af07f55d826b14c5fbe0188272431
https://doi.org/10.1007/978-3-319-16241-6_4
https://doi.org/10.1007/978-3-319-16241-6_4
Autor:
Fadi Towfic, Jason M. Funt, Shlomo Bakshi, Rivka Schwartz, David Ladkani, Michael R. Hayden, Benjamin Zeskind, Kevin D. Fowler, Maxim N. Artyomov, Eran Blaugrund
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e83757 (2014)
PLoS ONE, Vol 9, Iss 1, p e83757 (2014)
For decades, policies regarding generic medicines have sought to provide patients with economical access to safe and effective drugs, while encouraging the development of new therapies. This balance is becoming more challenging for physicians and reg
Autor:
Zeev Sthoeger, Jacov Levy, Yael Ben-Anat Porat, Zeev T. Handzel, Rivka Schwartz, Israel Zan-Bar, Ben-Zion Garty, Ronit Confino-Cohen
Publikováno v:
Clinical and diagnostic laboratory immunology. 6(6)
The mechanisms responsible for common variable immunodeficiency syndrome (CVID) are as yet unknown. In the present study, we show that the B-cell dysfunction in a subset of CVID patients is caused by defective protein tyrosine phosphorylation (PTP).
Autor:
Irit Altboum, Mona Iancovici Kidon, Michael Stein, Israel Zan-Bar, Rivka Schwartz, Zeev T. Handzel
Publikováno v:
BMC Family Practice
BMC Family Practice, Vol 5, Iss 1, p 23 (2004)
BMC Family Practice, Vol 5, Iss 1, p 23 (2004)
Background Symptomatic hypogammaglobulinemia in infancy and childhood (SHIC), may be an early manifestation of a primary immunodeficiency or a maturational delay in the normal production of immunoglobulins (Ig). We aimed to evaluate the natural cours